Louisiana HB 710: DRUGS/PRESCRIPTION:  Prohibits a manufacturer or wholesale distributor from engaging in unrestrained price increases in the sale of an essential off-patent or generic drug

Status: Read by title, under the rules, referred to the Committee on Health and Welfare. (as of 2018-03-21)

State: Louisiana · Session: 2018 · Bill: HB 710

Sponsors: Paul Hollis

View Louisiana HB 710 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.